Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications

6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications [Pg.89]

Some examples of marketed polysaccharides of fungal origin include  [Pg.90]

Welkmme WGP a particulate form of bakers yeast P-glucan, com-merciallized by Biothera (www.biotherapharma.com/healthcare) as an immunity enhancer food supplement. Wellmune WGP was the first yeast (J-glucan to be approved as a novel food by the the European Food Safety Authority (EFSA). It is used in foods, beverages and supplement products. [Pg.90]

Immunoglukan composed of a polysaccharide extract from the mushroom Pleurotus ostreatus, it is produced by PLEURAN s r.o. in EU and distributed by Immunoglukan P4H (Slovak Republic) (http //www.imu-noglukan.com). It is commercialized as an immxme system enhancer and for skin regeneration and protection. [Pg.90]

Polytetran/Scleroglucan introduced to the market by Pillsbury Cie, scleroglucan is now commercialized under various brand names, such as Actigum (Cargill) and Clearogel (Michel Mercier Products [M.M.P., [Pg.91]




SEARCH



Biomedical and pharmaceutical

Biomedical and pharmaceutical applications

Biomedical applications

Commercial applications

Commercial exploitation

Exploit

Exploitation

Exploiting

Pharmaceutical applications

Pharmaceuticals biomedical applications

Polysaccharides applications

© 2024 chempedia.info